Ansa Biotechnologies Announces First Shipments of Complex Clonal DNA Sequences to Customers in its Early Access Program
EMERYVILLE, Calif.--(BUSINESS WIRE)-- #DNAsynthesis--Ansa Biotechnologies, Inc., a pioneer of next-generation DNA synthesis, today announced that it has synthesized and delivered complex clonal DNA sequences to multiple customers participating in its Early Access Program. Additionally, Ansa’s first Early Access customer, Enoda Cellworks, has successfully completed functional testing of an initial set...
